Specifically, three spots, two of which related to Alpha-1-microglobulin (AMBP1 and AMBP2), and one identified as Ganglioside GM2 activator (SAP3) were increased in PCa (Figure 2a) compared to BPH (Figure 2b). The gene discussed is AMBP; the disease is benign prostatic hyperplasia.